Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Aug 04, 2026
Roblox (RBLX) Shares Drop -34% After Disappointing Q2 Results and Guidance

Roblox (RBLX) Shares Drop -34% After Disappointing Q2 Results and Guidance

Key Takeaways

  • Roblox shares plunged approximately 34% over the past 30 days, closing at $36.67 on August 3, 2026, following a disastrous Q2 earnings report and weak forward guidance.
  • The company reported second-quarter bookings of $1.56 billion, up only 8% year-over-year, while forecasting a 14–18% decline in Q3 bookings — well below Wall Street expectations.
  • Daily active users fell to 123 million, missing analyst estimates of 128.7 million and marking the third consecutive quarter of sequential DAU declines.
  • A controversial algorithm shift prioritizing retention over monetization, combined with age-verification safety measures, has pressured user engagement and spending.
  • Multiple analyst downgrades followed the earnings release, including cuts from Wedbush, BTIG, BMO Capital, and Benchmark, with price targets slashed across the board.
  • The stock has now lost roughly 55% year-to-date and trades near its 52-week low, with the company withdrawing its full-year 2026 outlook.

Roblox Corporation and Its Market Position

Roblox Corporation operates one of the world's largest online gaming and content-creation platforms, enabling users to build, share, and play immersive 3D experiences. Founded in 2004 and publicly listed on the NYSE since March 2021, the company generates revenue primarily through the sale of its virtual currency, Robux, which players use to purchase in-game items and experiences. Roblox also earns revenue from its growing advertising business, including integrated video ads and metaverse-based brand placements. The platform is particularly dominant among younger audiences — especially users under 13 — though the company has been actively working to attract older demographics and expand internationally. With millions of independent developers creating content on its platform, Roblox occupies a unique position at the intersection of gaming, social media, and the creator economy. Investors follow the stock closely for its user growth metrics, bookings trends, and progress toward profitability. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Recent Stock Price Performance: The Last 30 Days and Quarter

Roblox shares endured one of their most punishing stretches on record. Over the last 30 calendar days, the stock fell roughly 34%, tumbling from a July 2 close of $55.41 to $36.67 by the August 3 close. The steepest single-day decline occurred on July 31, when shares cratered nearly 27% — the worst trading day in company history — wiping out approximately $9 billion in market capitalization in a single session. Over the broader quarterly period, the stock shed about 17%, reflecting a sustained downtrend that accelerated sharply following the Q2 earnings release. The decline pushed shares dangerously close to the 52-week low of $33.88 and placed the stock more than 70% below its 52-week high of $142.00.

What Drove the 30-Day Collapse in RBLX

The overwhelming driver of the 30-day collapse was Roblox's Q2 2026 earnings report, released after market close on July 30. While the company posted a narrower-than-expected loss of $0.26 per share, revenue of $1.47 billion missed consensus estimates. More critically, bookings — a key metric reflecting deferred revenue and the real-time health of user spending — grew just 8% year-over-year to $1.56 billion. The Q3 guidance proved devastating: management forecast bookings to decline between 14% and 18%, far below the roughly $1.77 billion analysts had anticipated. Revenue growth was guided to only 4% to 10%.

Daily active users came in at 123 million, up 10% year-over-year but well short of the 128.7 million expected, marking a third straight quarterly sequential decline from the Q3 2025 peak of 152 million. Investors reacted to the company's explanation that an algorithm change — shifting recommendations from highly monetized viral games toward titles with stronger long-term retention — was depressing near-term spending. CFO Naveen Chopra warned that "monetization weakness is likely to continue." Compounding the pressure, age-verification safety measures implemented in response to regulatory and legal scrutiny have constrained user interaction and organic sign-ups. The company also withdrew its full-year 2026 guidance entirely, eliminating near-term visibility. From what I see, this combination of factors created a perfect storm for the shares.

Wall Street responded with a wave of downgrades. Wedbush cut Roblox from Outperform to Neutral ($40 target), BTIG downgraded to Sell ($30), Benchmark moved to Sell ($33), and BMO Capital slashed from Outperform to Market Perform ($45). Barclays reduced its target to $47 while maintaining an Equal Weight rating. The consensus rating shifted to Hold with an average price target of roughly $66, down sharply from earlier levels.

Broader Factors Behind the Quarterly Decline

Roblox's quarterly decline reflects a broader crisis of confidence that has been building for several months. Since peaking at 152 million DAUs in Q3 2025, the platform has shed nearly 30 million daily active users as pandemic-era engagement normalized and safety reforms disrupted the user experience. The company's Q1 2026 report in May already revealed weakening DAU trends and a revenue miss versus consensus, triggering a securities class action lawsuit from shareholders who purchased stock between October 2025 and April 2026. Although Roblox announced a $3 billion share buyback authorization in May — signaling management's belief that shares were undervalued — the stock continued to slide as insider selling and deteriorating engagement metrics weighed on sentiment. The July 30 earnings report crystallized fears that the platform's growth engine is fundamentally impaired, with the algorithm pivot, EU regulatory exposure, and intensifying competition from EA, Unity-based games, and MSFT-owned Minecraft all contributing to a challenging outlook.

What to Watch Next for RBLX

Looking ahead, the most critical catalyst for Roblox will be its Q3 2026 earnings report, tentatively scheduled for late October, where investors will scrutinize whether bookings and DAU trends stabilize or deteriorate further. Key metrics to monitor include daily active user counts, engagement hours, average bookings per DAU, and developer exchange fee trends. The success or failure of the algorithm transition — trading short-term monetization for long-term retention — will be a defining narrative. Additionally, regulatory developments in the European Union, where Roblox has now crossed the 45-million-user threshold triggering stricter oversight under the Digital Services Act, could add compliance costs and operational complexity. The ongoing securities class action lawsuit remains an overhang. On the positive side, the company's $3 billion buyback program, AI-powered creation tools like the Build feature, and expansion into older demographics and international markets represent potential long-term growth levers. Analyst sentiment remains divided, with price targets ranging from BTIG's $30 to Arete Research's $95, reflecting deep uncertainty about Roblox's ability to reignite profitable growth. I’m watching this closely as the next few quarters will clarify whether these pressures are temporary or structural.

AI Tools for Navigating Volatility

In periods of elevated volatility like Roblox's recent selloff, I often turn to AI-driven tools for data-backed decision-making. Tickeron's Trending AI Robots page showcases a curated selection of top-performing AI trading bots from a universe of hundreds that actively trade thousands of tickers across global markets. Only the most relevant and consistently strong performers appear in this section, spanning diverse strategies — from short-term momentum models to longer-duration swing and trend-following approaches. Each bot is backed by transparent performance metrics, allowing users to evaluate win rates, trade frequency, and risk profiles before committing capital. For investors navigating fast-moving stocks like RBLX, these AI tools offer an alternative lens grounded in statistical pattern recognition rather than emotion. In my view, they provide useful context when traditional fundamentals are under pressure.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: RBLX

RBLX in upward trend: price expected to rise as it breaks its lower Bollinger Band on July 31, 2026

RBLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 36 cases where RBLX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RBLX advanced for three days, in of 339 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RBLX as a result. In of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RBLX turned negative on July 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

RBLX moved below its 50-day moving average on July 30, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RBLX crossed bearishly below the 50-day moving average on July 31, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RBLX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RBLX entered a downward trend on August 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RBLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RBLX's P/B Ratio (172.414) is very high in comparison to the industry average of (13.182). P/E Ratio (0.000) is within average values for comparable stocks, (12.366). RBLX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.040). Dividend Yield (0.000) settles around the average of (0.034) among similar stocks. RBLX's P/S Ratio (4.604) is slightly higher than the industry average of (2.189).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RBLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are NetEase (NASDAQ:NTES), Electronic Arts (NASDAQ:EA), Take-Two Interactive Software (NASDAQ:TTWO).

Industry description

TVs, telephones, washing machines, home speakers and even home-office equipment like computers and printers…the list is virtually endless when it comes to consumer electronics and appliances. And, with ‘smarthomes’ increasingly becoming the reality, we could see a sharp surge in high-tech gadgets (including robotic appliances) making their way into our homes– and therefore spelling plenty opportunities in the related industries. Consumers account for 70% of US GDP, and their purchases of high-functioning electronics could make significant dents in the economy’s health. Sony Corp., Whirlpool and iRobot are some of the major consumer electronics/appliances makers.

Market Cap

The average market capitalization across the Electronics/Appliances Industry is 11.76B. The market cap for tickers in the group ranges from 78.65K to 403.7B. SSNLF holds the highest valuation in this group at 403.7B. The lowest valued company is BHAT at 78.65K.

High and low price notable news

The average weekly price growth across all stocks in the Electronics/Appliances Industry was 1%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 1%. MYPS experienced the highest price growth at 17%, while RBLX experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Electronics/Appliances Industry was 102%. For the same stocks of the Industry, the average monthly volume growth was 368% and the average quarterly volume growth was 82%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 70
Price Growth Rating: 56
SMR Rating: 76
Profit Risk Rating: 93
Seasonality Score: -33 (-100 ... +100)
View a ticker or compare two or three
RBLX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry ElectronicsAppliances

Profile
Details
Industry
N/A
Address
970 Park Place
Phone
+1 888 858-2569
Employees
2457
Web
https://www.corp.roblox.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.